Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
By L. Walensky, A. Kung, I. Escher, T. Malia, Scott Barbuto, R. Wright, G. Wagner, G. Verdine, S. Korsmeyer. Science, 2004
1,269 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/3433b10848fd9d713a18f94ca2872fa2e67fcb96
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Simone Fulda
- A. Letai
- Philip J. Hajduk
- Simon N. Willis
- M. S. Ola
- K. Debatin
- Yong S. Chang
- John Calvin Reed
Citations in the corpus
- Role of Bcl-2 family proteins and caspases in the regulation of apoptosis (2011, background): “A number of therapeutic approaches are undergoing using an antisense RNA [208], various small molecules [209–218, 222, 223], and peptidic compounds [219–221, 224, 225] classified as potential therapeutics to target the pathway of apoptosis, as briefly summarized in Table 2.”
- An inhibitor of Bcl-2 family proteins induces regression of solid tumours (2005, background): “ABT-737 by itself was cytotoxic against the t(14;18) chromosomal translocation-containing lymphoma cell lines RS11380, DoHH2 and SuDHL-4 (median effective concentration EC50 1⁄4 0.”
- Apoptosis and Molecular Targeting Therapy in Cancer (2014, unknown): “, HA14-1; [103]) and BH3 peptidomimetics [106].”
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy (2013, methodology): “To determine dissociation constants for peptide–protein interaction, afluorescencepolarization assay (FPA) was used inwhich 10 nMof the fluorescently labeled analog of the linear peptide ATSP-3848 (specifically, FAM-β-Ala-Leu-Thr-Phe-Glu-His-Tyr-Trp-AlaGln-Leu-Thr-Ser-NH2 [FAM-ATSP-3848]) was incuba”